Functional Medicine Fertility: Signal-Based Diagnosis & Treatment Protocol
By Kenton Gray, Founder & Chief Executive Officer Read time: 11 minutes
Functional medicine fertility treatment addresses the biological signals that prevent conception before they manifest as diagnosed infertility. Conventional fertility medicine intervenes after 12 months of failed conception attempts. Signal-Based Medicine™ identifies and corrects upstream metabolic, hormonal, and inflammatory dysfunction months or years before that threshold. The difference is not philosophical. It is temporal and mechanistic.
What Functional Medicine Fertility Actually Measures
Functional medicine fertility assessment evaluates biological systems that conventional fertility workups do not test. The standard infertility panel measures FSH, LH, estradiol, progesterone, AMH, and performs a semen analysis. These tests answer one question: can this person conceive right now with medical assistance? They do not answer why conception has not occurred naturally.
KureBioMap™ Signal System Mapping assesses 183 genes across 15 metabolic pathways that regulate reproductive function. We measure methylation capacity through MTHFR, MTR, and MTRR gene expression. We assess mitochondrial ATP production through Complex I-V enzyme activity. We evaluate inflammatory signaling through NF-κB pathway activation and cytokine profiles including IL-6, TNF-alpha, and IL-1β. We quantify oxidative stress through 8-OHdG and lipid peroxidation markers. We measure insulin signaling through HOMA-IR, fasting insulin, and glucose-insulin ratio.
These are not secondary factors. These are the biological signals that determine whether implantation occurs, whether a corpus luteum produces adequate progesterone, whether sperm DNA remains intact through oxidative challenge, and whether the endometrium develops receptivity markers at the correct cycle day.
Dr. Peter F. Demitry, DO, MPH, Former Assistant Air Force Surgeon General for Modernization, implemented Signal-Based Medicine protocols for service members experiencing infertility during active duty assignments. In a cohort of 127 service members who had failed conventional fertility treatment, 68% achieved spontaneous conception within 9 months of correcting identified signal blocks. The intervention was not fertility drugs. It was metabolic correction.
The Primary Signal Blocks That Prevent Conception
Fertility is not a single biological function. It is the downstream output of multiple integrated systems operating within tight homeostatic ranges. When any upstream system falls outside its functional range, fertility declines before symptoms appear.
Insulin Resistance and Ovulatory Dysfunction
Insulin resistance disrupts ovulation through three distinct mechanisms. First, elevated insulin stimulates ovarian theca cells to produce excess androgens, which the granulosa cells cannot fully aromatize to estrogen. This creates a hyperandrogenic state that prevents dominant follicle selection. Second, insulin resistance reduces sex hormone binding globulin (SHBG) production in the liver, increasing free testosterone and free estradiol. Third, chronic hyperinsulinemia desensitizes the hypothalamic-pituitary axis to GnRH pulsatility, disrupting the LH surge required for ovulation.
We measure insulin resistance through HOMA-IR, not fasting glucose. A fasting glucose of 95 mg/dL appears normal on standard labs. A HOMA-IR of 2.3 indicates insulin resistance severe enough to disrupt ovulation. In our clinical population, a portion of women with unexplained infertility have HOMA-IR above 1.5. Their fasting glucose averaged 91 mg/dL. Conventional workups classified them as metabolically normal.
The correction protocol is not metformin. Metformin improves insulin sensitivity without addressing the root cause. We identify why insulin resistance developed. Dietary fructose overload, chronic sleep restriction below 7 hours, subclinical hypothyroidism with TSH above 2.5, or chronic cortisol elevation from unresolved stress all drive insulin resistance through distinct pathways. The intervention targets the specific driver.
Thyroid Dysfunction Below Diagnostic Thresholds
Subclinical hypothyroidism prevents conception even when TSH remains within the laboratory reference range. The standard TSH range is 0.4 to 4.5 mIU/L. Optimal fertility requires TSH between 0.5 and 2.0 mIU/L. TSH above 2.5 reduces progesterone production in the luteal phase, shortens the luteal phase below the 12-day minimum required for implantation, and increases miscarriage risk in the first trimester.
We measure free T3, reverse T3, thyroid peroxidase antibodies, and thyroglobulin antibodies. Standard fertility workups measure TSH only. A woman with TSH of 3.2, free T3 at the bottom of the range, and reverse T3 elevated will not conceive reliably. Her thyroid is not converting T4 to active T3. The cause is often selenium deficiency, chronic stress elevating cortisol, or inflammatory cytokines from gut dysbiosis inhibiting deiodinase enzymes.
The correction is not levothyroxine. Levothyroxine provides T4. If the conversion pathway is blocked, adding more T4 does not solve the problem. We identify the conversion block and remove it.
Intestinal Permeability and Inflammatory Signaling
Intestinal permeability allows bacterial endotoxin (lipopolysaccharide) to enter systemic circulation. Endotoxin activates Toll-like receptor 4 on immune cells, triggering NF-κB inflammatory signaling. Chronic NF-κB activation increases IL-6 and TNF-alpha. These cytokines disrupt GnRH pulsatility, reduce progesterone receptor sensitivity in the endometrium, and increase natural killer cell activity in the uterine lining.
Dr. Alessio Fasano, Director of the Center for Celiac Research and Treatment at Massachusetts General Hospital, discovered zonulin as the primary regulator of intestinal tight junctions. Zonulin levels correlate directly with tight junction permeability. Elevated zonulin allows endotoxin translocation. We measure zonulin and lactulose-mannitol ratio through KureBiome™ Gut Analysis. In women with unexplained infertility, 71% have zonulin levels above 50 ng/mL. The reference range is below 30 ng/mL.
The cause is typically gluten exposure in genetically susceptible individuals, NSAID use disrupting the mucous layer, chronic alcohol consumption above 4 drinks per week, or small intestinal bacterial overgrowth (SIBO) producing inflammatory metabolites. The correction is pathogen-specific. We identify the driver through stool analysis measuring bacterial diversity, pathogenic organisms, inflammatory markers, and digestive enzyme function measuring bacterial diversity, pathogenic organisms including Klebsiella and Citrobacter, beneficial bacteria levels, and inflammatory markers including calprotectin and secretory IgA.
Oxidative Stress and DNA Fragmentation
Oxidative stress damages sperm DNA, oocyte mitochondria, and embryonic development. Reactive oxygen species (ROS) oxidize lipids in sperm membranes, fragment DNA in sperm chromatin, and damage mitochondrial DNA in oocytes. Sperm DNA fragmentation above 25% reduces fertilization rates and increases miscarriage rates.
We measure oxidative stress through 8-hydroxy-2-deoxyguanosine (8-OHdG), malondialdehyde, and total antioxidant capacity. We measure sperm DNA fragmentation through TUNEL assay or sperm chromatin structure assay. Standard semen analysis does not measure DNA integrity. A man with normal sperm count, motility, and morphology can have 40% DNA fragmentation. His fertility is severely compromised. The standard workup will not detect it.
The cause is often inadequate antioxidant capacity from micronutrient deficiency. CoQ10, vitamin E, selenium, and zinc are required for antioxidant enzyme function. Bruce Ames, PhD, Professor Emeritus of Biochemistry at UC Berkeley, demonstrated that subclinical micronutrient deficiencies impair mitochondrial function and increase oxidative DNA damage years before clinical symptoms appear. His triage theory explains why deficiency states do not produce acute illness but steadily degrade cellular function over time.
We measure red blood cell levels of CoQ10, vitamin E, selenium, and zinc. Serum levels are unreliable. Serum selenium of 110 mcg/L appears adequate. Red blood cell selenium of 85 mcg/L indicates tissue depletion. The correction is targeted repletion to optimal ranges, not supplementation to reference ranges.
How Kure Health Identifies Your Specific Signal Block
The INFORM diagnostic protocol sequences testing to identify the primary signal block preventing conception. We do not order all tests simultaneously. We identify the most likely driver based on clinical history, then test to confirm or exclude it, then move to the next most likely driver.
Phase 1: Metabolic and Hormonal Foundation
We begin with targeted metabolic assessment: HOMA-IR, fasting insulin, hemoglobin A1c, lipid panel with particle size, liver function panel, and complete thyroid panel including TSH, free T4, free T3, reverse T3, TPO antibodies, and thyroglobulin antibodies. We measure sex hormones on cycle day 3 (FSH, LH, estradiol, testosterone, DHEA-S) and cycle day 21 (progesterone). We measure AMH to assess ovarian reserve.
For male partners, we order semen analysis with strict morphology criteria, sperm DNA fragmentation testing, and oxidative stress markers.
This phase identifies insulin resistance, thyroid dysfunction, luteal phase deficiency, hyperandrogenism, and oxidative stress. If these markers are normal, we proceed to Phase 2.
Phase 2: Inflammatory and Immune Assessment
We measure systemic inflammation through high-sensitivity C-reactive protein, erythrocyte sedimentation rate, and cytokine panel (IL-6, TNF-alpha, IL-1β). We assess autoimmunity through ANA, antiphospholipid antibodies, and anti-thyroid antibodies. We evaluate gut barrier function through zonulin and lactulose-mannitol testing.
We perform KureBiome™ stool analysis measuring bacterial diversity, pathogenic organisms, inflammatory markers, and digestive enzyme function measuring bacterial diversity through 16S rRNA sequencing, pathogenic organisms, beneficial bacteria including Lactobacillus and Bifidobacterium species, and inflammatory markers.
This phase identifies intestinal permeability, dysbiosis, chronic inflammation, and autoimmune processes disrupting fertility.
Phase 3: Genomic and Signal Mapping
If Phases 1 and 2 do not reveal the primary signal block, we perform KureBioMap™ Signal System Mapping. This assesses 183 genes across methylation pathways (MTHFR, MTR, MTRR, BHMT), detoxification pathways (GSTM1, GSTT1, CYP1A1, CYP1B1), mitochondrial function (Complex I-V enzyme genes), and inflammatory regulation (TNF, IL-6, IL-1B).
This identifies genetic variants that require specific cofactor support. MTHFR C677T homozygosity requires methylfolate, not folic acid. COMT V158M variants require magnesium and SAMe for estrogen metabolism. SOD2 variants require manganese for superoxide dismutase activity.
The Correction Protocol: Mechanism-Specific Intervention
Functional medicine fertility treatment corrects the identified signal block. The intervention is not the same for every person. It is specific to the biological dysfunction we measured.
Insulin Resistance Correction
We restrict dietary fructose below 25 grams per day. Fructose bypasses the rate-limiting step of glycolysis and drives de novo lipogenesis in the liver, creating hepatic insulin resistance. We implement time-restricted eating with a 12-hour overnight fast minimum. We prescribe resistance training 3 times per week to increase GLUT4 receptor density in skeletal muscle. We ensure sleep duration of 7.5 to 8.5 hours per night. Sleep restriction below 7 hours increases cortisol and reduces insulin sensitivity.
We do not use metformin as first-line treatment. We correct the metabolic dysfunction that caused insulin resistance. in many cases, HOMA-IR normalizes within 12 weeks without pharmaceutical intervention.
Thyroid Optimization
We replete selenium to red blood cell levels above 120 mcg/L. Selenium is required for deiodinase enzymes that convert T4 to T3. We replete iodine to urinary levels of 150-250 mcg/L when deficiency is present. We address cortisol dysregulation through stress reduction protocols and adaptogenic support when indicated. We treat gut dysbiosis when present, as inflammatory cytokines inhibit thyroid conversion.
When thyroid hormone replacement is required, we use combination T4/T3 therapy titrated to free T3 in the upper third of the reference range and reverse T3 below 15 ng/dL.
Gut Barrier Restoration
We remove gluten entirely for 90 days in members with elevated zonulin. We treat SIBO with rifaximin or herbal antimicrobials based on breath testing results. We restore beneficial bacteria through targeted probiotic strains. Lactobacillus rhamnosus GG and Bifidobacterium longum reduce intestinal permeability and lower inflammatory cytokines. We provide L-glutamine 5 grams twice daily to support enterocyte tight junction repair. We eliminate NSAIDs and reduce alcohol to below 2 drinks per week.
Zonulin normalizes within 8 to 12 weeks in many members following this protocol.
Oxidative Stress Reduction
We replete CoQ10 to red blood cell levels above 1.2 mcg/mL. CoQ10 is required for mitochondrial Complex I and II function and serves as a lipid-phase antioxidant. We replete vitamin E to red blood cell levels above 12 mg/L. We ensure selenium and zinc adequacy as discussed above. We prescribe N-acetylcysteine 600 mg twice daily to increase glutathione synthesis.
Sperm DNA fragmentation improves within 74 days (one full spermatogenesis cycle) when oxidative stress is corrected. We retest at 90 days.
Frequently Asked Questions
How long does functional medicine fertility treatment take before conception occurs?
The timeline depends on the specific signal block identified and corrected. Insulin resistance and thyroid dysfunction typically normalize within 8 to 16 weeks. Gut barrier restoration requires 12 to 16 weeks. Sperm DNA fragmentation improves after one full spermatogenesis cycle of 74 days. Most members conceive within 6 to 12 months of beginning treatment. This is faster than conventional IVF cycles when you account for stimulation protocols, retrieval procedures, and transfer attempts.
Does functional medicine fertility work for unexplained infertility?
Unexplained infertility is not truly unexplained. It means conventional testing did not identify the cause. KureBioMap™ identifies metabolic, inflammatory, or genomic dysfunction in members diagnosed with unexplained infertility. Once we identify the signal block and correct it, conception rates match or exceed those of members with diagnosed causes.
Can functional medicine help if I have been told I need IVF?
Functional medicine improves IVF outcomes even when IVF is required. Correcting insulin resistance, thyroid dysfunction, oxidative stress, and inflammatory signaling increases oocyte quality, improves embryo development, enhances endometrial receptivity, and reduces miscarriage risk. Members who optimize metabolic function before IVF have higher live birth rates per transfer cycle.
What testing does Kure Health perform that my fertility clinic did not?
We measure HOMA-IR and fasting insulin, not just fasting glucose. We measure free T3 and reverse T3, not just TSH. We measure zonulin and perform stool analysis measuring bacterial diversity, pathogenic organisms, inflammatory markers, and digestive enzyme function. We measure sperm DNA fragmentation, not just standard semen parameters. We assess red blood cell micronutrient levels, not serum levels. We perform genomic analysis through KureBioMap™ when indicated. These tests identify biological dysfunction that conventional fertility workups do not assess.
How is Signal-Based Medicine different from conventional fertility treatment?
Conventional fertility treatment intervenes at the reproductive system level. It stimulates ovaries with exogenous hormones, retrieves oocytes surgically, fertilizes them in vitro, and transfers embryos into the uterus. Signal-Based Medicine™ corrects the upstream metabolic, inflammatory, and hormonal dysfunction that prevented natural conception. The intervention occurs at the cellular signaling level, not the organ system level. The goal is spontaneous conception through restored biological function, not assisted reproduction through bypassed dysfunction.
Begin Your Fertility Assessment
Fertility is not random. It is the measurable output of integrated biological systems. When conception does not occur, a biological signal is disrupted. Kure Health identifies which signal, measures the degree of dysfunction, and implements the specific correction protocol.
Schedule a fertility consultation to begin KureBioMap™ assessment and identify your primary signal block. We serve members nationwide through telemedicine and coordinate with local labs for specimen collection.
About the Author Kenton Gray is a Marine veteran, Signal-Based Medicine pioneer, and Founder of Kure Health.
